OptimizeRx Corporation (OPRX)
The price, the headline numbers and the latest news, in one place.
OptimizeRx Corporation (OPRX) Stock Price, Analysis & Data
No data available
| Bid | 5.77 |
| Market Cap | 146.45M |
| Revenue (ttm) | 98.65M |
| Net Income (ttm) | 4.6M |
| 1.05 | |
| 0.25 | |
| 31.1 | |
| 7.35 | |
| P/B (ttm) | 1.12 |
| P/S (ttm) | 1.48 |
| Earnings Date | Nov 5, 2026 |
| Ask | 9.84 |
| Volume | 130,744 |
| Avg. Volume (20D) | 340,887 |
| Open | 8.05 |
| Previous Close | 7.96 |
| Day's Range | 7.59 - 8.12 |
| 52-Week Range | 4.54 - 22.25 |
| Analyst | Strong Buy |
| Price Target | 11 (42.67%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About OPRX
OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support me...
Financial Performance
In 2025, OptimizeRx's revenue was 109.43M, an increase of 18.78% compared to the previous year's 92.13M. Earnings were 5.13M, a decrease of -125.52%.
Financial StatementsAnalyst Forecast
According to 5 analyst ratings, the average rating for OPRX stock is "Strong Buy". The 12-month stock price forecast is 11, which is upside of 42.67% from the latest price.
Stock ForecastsEarnings Surprise
- Revenue of $19.84M misses estimates by $0, with -9.50% YoY decline.
- EPS of 0.16 exceeds estimates by 0.05, with 100.00% YoY growth.
Analysts project revenue of ... Upgrade
